PTAB Got Conception Analysis Wrong For CRISPR Patent, Federal Circuit Says
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel said the U.S. Patent Trial and Appeal Board (PTAB) wrongly required scientists from the University of California and other facilities...To view the full article, register now.
Already a subscriber? Click here to view full article